safety and efficacy of nivolumab in mrcc: final analysis from the nivoren study
Published 5 years ago • 295 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
1:59
real-world vs. clinical trial: efficacy of nivolumab in mrcc
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
3:33
genomic pathway of gut microbiome predicts efficacy of nivolumab in advanced gc
-
1:30
targeted therapies for the treatment of mrcc after nivolumab-ipilimumab failure
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
3:12
opdivo (nivolumab) the immunotherapy cancer treatment
-
6:10
nivolumab: a new standard-of-care
-
4:51
hcc: nivolumab's side effects
-
1:22
dr. mcdermott on major findings of efficacy and safety of nivolumab in rcc
-
2:08
nivolumab with ipilimumab for mrcc
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
3:46
nivoren: nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinoma
-
10:22
dr. karasic on phase ii trial of nivolumab and ipilimumab
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer
-
2:03
integrated genomic correlates of response to pd-1 inhibitor nivolumab in mrcc
-
1:56
nivolumab and ipilimumab for advanced bcvh
-
1:32
dr. voss on phase i/ii trial data of medi0680/durvalumab versus nivolumab in mrcc
-
4:08
nivoren-getug afu-26 trial
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
1:43
nivolumab, ipilimumab and panitumumab in mcrc
-
1:39
advancements in use of combination drugs in clinical trials: nivolumab, pembrolizumab, and more
-
1:54
checkmate 214 trial in rcc updates